Find uplifting stories about heroes, innovations, and solutions
8 results for "combination therapy"
Scientists discovered that combining natural compounds found in grapes and berries with existing Alzheimer's drugs could make treatments safer and more effective. The breakthrough could help nearly a million Canadians expected to face dementia by 2030.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
A groundbreaking combination therapy for multiple myeloma just won FDA approval, nearly tripling survival rates compared to standard treatment. This could become the new standard of care for thousands of cancer patients facing relapse.
A breakthrough combination therapy is giving aggressive leukemia patients new hope, nearly doubling remission rates and opening the door to life-saving transplants. The treatment developed in Germany could soon become the new standard of care.
Scientists discovered a breakthrough treatment that targets "zombie cells" causing kidney damage in diabetic patients. The combination therapy improved kidney function and reduced inflammation in early studies.
Scientists at UCLA have achieved breakthrough results in treating advanced colorectal cancer, with a new combination therapy doubling two-year survival rates. The research team is also making major strides in prevention, from mailing free screening kits to developing powerful cancer vaccines.
A groundbreaking treatment for aggressive breast cancer just got FDA approval after helping patients live 14 months longer without their disease progressing. The combination therapy offers new hope for thousands of women battling HER2-positive breast cancer.
A groundbreaking combination therapy has left nearly 9 in 10 hepatitis D patients with no detectable virus after two years of treatment. The results could transform care for a disease that often leads to liver failure within five years.